The global macular degeneration treatment market is estimated to grow at a CAGR of nearly 7.0% during the forecast period. The major factors contributing to the market growth include a significant rise in the prevalence of age-related macular degeneration (AMD) and rising geriatric population base. As per the International Agency for the Prevention of Blindness (IAPB), AMD is the third most common cause of blindness across the globe. It is the major cause of blindness in higher-income countries with geriatric populations. AMD accounts for nearly 5% of blindness across the globe. The major risk factors that lead to the rising incidences of AMD include genetic factors, age, and tobacco smoking.

Request a free sample of our report on Global Macular Degeneration Treatment Market: https://www.omrglobal.com/request-sample/macular-degeneration-treatment-market



AMD is the major cause of permanent central vision loss among people aged 65 and over in developed countries. The incidence of macular degeneration is expected to rise continuously coupled with the significant rise in ageing population. This, in turn, will drive the demand for reliable and effective macular degeneration treatment. The treatment efforts for AMD is aimed to keep the central vision as long as possible. The treatment alternatives available for wet AMD include Bevacizumab (Avastin), Ranibizumab (Lucentis), and Aflibercept (Eylea) drugs. These medications are injected into the vitreous cavity of the eye, which decreases the leakage from the retinal blood vessels. A large number of patients receiving these treatments will need lifelong therapy at the intervals of 1-3 months.

A full report of Global Macular Degeneration Treatment Market Is available at https://www.omrglobal.com/industry-reports/macular-degeneration-treatment-market



Global Macular Degeneration Treatment Market Segmentation

By Type

Dry Age-Related Macular Degeneration

Wet Age-Related Macular Degeneration

By Route of Administration

Intravitreal

Intravenous

By Distribution Channel

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Regional Analysis

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe

Asia-Pacific

China

India

Japan

Rest of Asia-Pacific

Rest of the World

Company Profiles

Alkahest, Inc.

Allergan plc

Amgen Inc.

Bausch Health Companies Inc.

Boehringer Ingelheim GmbH

Clearside Biomedical, Inc.

Exonate Ltd.

F. Hoffman La-Roche AG

Gemini Therapeutics, Inc.

IVERIC bio, Inc.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/macular-degeneration-treatment-market



About Us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404